Nanomaterials (Dec 2022)
CeO<sub>2</sub>-Azacrown Conjugate as a Nanoplatform for Combined Radiopharmaceuticals
Abstract
This study is one of the first attempts to assess CeO2 nanoparticles as a nanoplatform for radiopharmaceuticals with radionuclides. The process of functionalization using a bifunctional azacrown ligand is described, and the resulting conjugates are characterized by IR and Raman spectroscopy. Their complexes with 207Bi show a high stability in medically relevant media, thus encouraging the further study of these conjugates in vivo as potential combined radiopharmaceuticals.
Keywords